On the market: An update on surgical business sale

Article

Last summer, Pfizer Inc. announced it was selling the surgical ophthalmic business acquired in the acquisition of Pharmacia Inc. (See Ophthalmology Times, Sept. 1, 2003 issue, Page 3).

Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
ChatGPT may have a future use in glaucoma

ChatGPT may have a future use in glaucoma

Article
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Podcast
Therapeutic in development to take on diabetic macular edema

Therapeutic in development to take on diabetic macular edema

Article
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention

Podcast
Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410

Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410

Article
Stress resilience–enhancing drugs: New class of small molecules holds promise

Stress resilience–enhancing drugs: New class of small molecules holds promise

Article
© 2024 MJH Life Sciences

All rights reserved.